It’s Not East Being Green: The FDA’s Duties Under NEPA and ESA When Approving New Drugs and Biological Products

Harvard Environmental Law Review
Publication
August 5, 2024
Please visit Harvard Environmental Law Review to view this article.
Related Practices
RELATED PEOPLE
Savannah Bergeron
Associate
YOU MIGHT ALSO LIKE
Client Alert November 13, 2025
The OBBBA modernizes Opportunity Zones with permanent incentives that strengthen financing for stadiums, entertainment venues, and mixed-use districts. This update expands opportunities for developers while requiring careful planning to meet compliance and community goals.
Awards November 11, 2025
Bilzin Sumberg CEO and Managing Partner Albert E. Dotson, Jr. has been honored in Florida Trend’s 500 Most Influential Business Leaders. His leadership in law, major infrastructure projects, and extensive civic involvement underscores his broad impact across Florida.
Client Alert November 11, 2025
On October 14, 2025, approximately three months after the revised opinion in Avila v. Biscayne 21 Condominium, Inc., 50 Fla. L. Weekly D1509 (Fla. 3d DCA July 10, 2025), the Florida Supreme Court declined to accept jurisdiction over the Third District Court of Appeal’s certified question on co...
VIEW MORE